uniQure Announces Results for Fourth Quarter and Financial Year 2015

Go back to uniQure Announces Results for Fourth Quarter and Financial Year 2015

Oppenheimer Cuts Price Target on uniQure (QURE) to $23 Following 4Q

April 5, 2016 8:13 AM EDT

Oppenheimer maintained an Outperform rating on uniQure BV (NASDAQ: QURE), and cut the price target to $23.00 (from $50.00),following the company's 4Q. QURE ended the year with 203.5M (~$230M USD) in cash which estimates show will fund operations through 2018. Next hemophilia data is set to come out in 2Q16, while... More